BioSpace News Archive

Drug Development

Trial Touts 81% Response Rate in Locally Advance Breast Cancer

Researchers have published a study describing how chemotherapy and a drug used to treat cardiac failure is able to regress tumor growth of patients with triple negative breast cancer.

December 16, 2021
·
2 min read
·
Mark Terry
Drug Development

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19

Biopharmaceutical companies across the world are fighting an increasingly important battle against COVID-19: the struggle to treat the disease.

December 16, 2021
·
7 min read
·
Kaylei Whalen
Drug Development

Biogen Preps for Post-Approval Testing of Controversial Alzheimer’s Drug

Biogen and Eisai released an update on the Phase IV post-marketing confirmatory study and plan to submit the final protocol to the FDA in March 2022 and launch patient screening in May 2022.

December 16, 2021
·
3 min read
·
Mark Terry
Business

Horizon Forges Autoimmune Disease Collaboration Valued at $1.5 Billion

The agreement between the two companies includes a lead, potential first-in-class preclinical candidate, and research collaboration to jointly develop the additional novel candidates.

December 16, 2021
·
2 min read
·
Alex Keown
Policy

COVID-19 News: Vaccines Prevented 1.1 Million U.S. Deaths and More

A recent study estimates that in the U.S. alone the vaccines saved 1.1 million lives and prevented 10.3 million hospitalizations. For that and more COVID-19 news, continue reading.

December 16, 2021
·
3 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, Dec. 17

As 2021 moves closer to its end, biopharma and life sciences companies from across the globe continue to strengthen their leadership teams and boards with these Movers & Shakers.

December 16, 2021
·
6 min read
·
Alex Keown
Policy

BeiGene, Other Biotechs Escape U.S. Blacklisting of 34 Chinese Companies and Organizations

BeiGene and other China-based pharma companies have been nervously watching the Biden administration and its response to some companies in that region that have allegedly been involved with the Chinese military’s weapons programs and human rights violations.

December 16, 2021
·
2 min read
·
Alex Keown
Policy

New Research Points to Why Omicron is Spreading More Rapidly

As the Omicron variant of the SARS-CoV-2 virus sweeps much of the globe, scientists are digging into why this particular mutation is spreading even more rapidly than its predecessors.

December 16, 2021
·
2 min read
·
Kate Goodwin
FDA

Calliditas Scores Milestone First Approval for IgAN Proteinuria Drug TARPEYO

It is also a milestone for the immunoglobulin A nephropathy (IgAN) community, as TARPEYO becomes the first and only FDA-approved treatment to reduce proteinuria in this condition.

December 16, 2021
·
2 min read
·
Vanessa Doctor, RN
Biotech Beach

How Pharma and Academia are Tackling the Opioid Epidemic

Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.

December 16, 2021
·
5 min read
·
Gail Dutton